Market Currents
NPS Pharmaceuticals (NPSP +04%) says the FDA has approved Gattex for the treatment of adult...
-
Friday, December 21, 2012, 4:04 PM ETNPS Pharmaceuticals (NPSP +04%) says the FDA has approved Gattex for the treatment of adult patients with short bowel syndrome who are dependent on parenteral support. The company says Gattex will be available in Q113.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
